Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 89 (6), 2583-9

Medical Consequences of Obesity

Affiliations
Review

Medical Consequences of Obesity

George A Bray. J Clin Endocrinol Metab.

Abstract

Obesity is an epidemic disease that threatens to inundate health care resources by increasing the incidence of diabetes, heart disease, hypertension, and cancer. These effects of obesity result from two factors: the increased mass of adipose tissue and the increased secretion of pathogenetic products from enlarged fat cells. This concept of the pathogenesis of obesity as a disease allows an easy division of disadvantages of obesity into those produced by the mass of fat and those produced by the metabolic effects of fat cells. In the former category are the social disabilities resulting from the stigma associated with obesity, sleep apnea that results in part from increased parapharyngeal fat deposits, and osteoarthritis resulting from the wear and tear on joints from carrying an increased mass of fat. The second category includes the metabolic factors associated with distant effects of products released from enlarged fat cells. The insulin-resistant state that is so common in obesity probably reflects the effects of increased release of fatty acids from fat cells that are then stored in the liver or muscle. When the secretory capacity of the pancreas is overwhelmed by battling insulin resistance, diabetes develops. The strong association of increased fat, especially visceral fat, with diabetes makes this consequence particularly ominous for health care costs. The release of cytokines, particularly IL-6, from the fat cell may stimulate the proinflammatory state that characterizes obesity. The increased secretion of prothrombin activator inhibitor-1 from fat cells may play a role in the procoagulant state of obesity and, along with changes in endothelial function, may be responsible for the increased risk of cardiovascular disease and hypertension. For cancer, the production of estrogens by the enlarged stromal mass plays a role in the risk for breast cancer. Increased cytokine release may play a role in other forms of proliferative growth. The combined effect of these pathogenetic consequences of increased fat stores is an increased risk of shortened life expectancy.

Similar articles

  • Sleep Apnea Is a Manifestation of the Metabolic Syndrome
    AN Vgontzas et al. Sleep Med Rev 9 (3), 211-24. PMID 15893251. - Review
    Obstructive sleep apnea (OSA) is a prevalent disorder particularly among middle-aged, obese men, although its existence in women as well as in lean individuals is increas …
  • Adipose Tissue Dysfunction in Obesity
    M Blüher. Exp Clin Endocrinol Diabetes 117 (6), 241-50. PMID 19358089. - Review
    The incidence of obesity has increased dramatically during recent decades. Obesity will cause a decline in life expectancy for the first time in recent history due to num …
  • From Obesity to Diabetes
    U Keller. Int J Vitam Nutr Res 76 (4), 172-7. PMID 17243079. - Review
    The prevalence of obesity has been increasing dramatically in the last decades in the whole world, not only in industrialized countries but also in developing areas. A ma …
  • Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
    M Bastien et al. Prog Cardiovasc Dis 56 (4), 369-81. PMID 24438728. - Review
    The prevalence of obesity has increased worldwide and is a source of concern since the negative consequences of obesity start as early as in childhood. The most commonly …
  • Liver Fat in Obesity: Role of Type 2 Diabetes Mellitus and Adipose Tissue Distribution
    L Bozzetto et al. Eur J Clin Invest 41 (1), 39-44. PMID 20825466.
    Type 2 diabetes is associated with increased fat accumulation in the liver, independent of obesity and whole-body insulin resistance. The increased liver fat in DO patien …
See all similar articles

Cited by 326 PubMed Central articles

See all "Cited by" articles
Feedback